Robert Power Net Worth

Robert Power biography

Robert N. Power is an Independent Director of Company. He is currently a corporate director. From 2009 to 2011, Mr. Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing. Mr. Power has over 25 years’ experience working in the pharmaceutical and biotechnology industry, which he gained serving in a number of leadership positions with Wyeth from 1985 through 2007, including Director — New Product Development, Managing Director — U.K./Ireland, Vice President — Global Marketing, President — Europe, Middle East, Africa, President — International and Executive Vice President — Global Business Operations. Mr. Power also has completed the Director Professionalism course offered by the National Association of Corporate Directors.

What is the salary of Robert Power?

As the Independent Director of Bausch Health Companies Inc, the total compensation of Robert Power at Bausch Health Companies Inc is $392,500. There are 12 executives at Bausch Health Companies Inc getting paid more, with Joseph Papa having the highest compensation of $17,141,600.

How old is Robert Power?

Robert Power is 63, he's been the Independent Director of Bausch Health Companies Inc since 2008. There are 10 older and 11 younger executives at Bausch Health Companies Inc. The oldest executive at Bausch Health Companies Inc is Richard De Schutter, 79, who is the Independent Director.

What's Robert Power's mailing address?

Robert's mailing address filed with the SEC is 400 SOMERSET CORPORATE BLVD, , BRIDGEWATER, NJ, 08807.

Insiders trading at Bausch Health Companies Inc

Over the last 6 years, insiders at Bausch Health Companies Inc have traded over $2,786,244 worth of Bausch Health Companies Inc stock and bought 6,317,686 units worth $110,094,785 . The most active insiders traders include John Paulson, Argeris N Karabelas y Brett Icahn. On average, Bausch Health Companies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $824,564. The most recent stock trade was executed by Seana Carson on 5 September 2024, trading 13,370 units of BHC stock currently worth $83,028.

What does Bausch Health Companies Inc do?

bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###

Bausch Health Companies Inc executives and stock owners

Bausch Health Companies Inc executives and other stock owners filed with the SEC include:

• Joseph Papa,
  Chairman of the Board, Chief Executive Officer
• Paul Herendeen,
  Chief Financial Officer, Executive Vice President
• Joseph C. Papa,
  CEO & Chairman
• Thomas Appio,
  President & Co-Head Bausch + Lomb/International
• William Humphries,
  
• Christina Ackermann,
  Executive Vice President, General Counsel
• Thomas J. Appio,
  Pres & Co-Head Bausch + Lomb/International
• Paul S. Herendeen,
  Exec. VP and Advisor to Chairman & CEO
• Joseph Gordon,
  President & Co-Head Bausch + Lomb/International
• Christina M. Ackermann,
  Exec. VP, Gen. Counsel & Head of Commercial Operations
• Thomas Ross,
  Lead Independent Director
• Russel Robertson,
  Independent Director
• Robert Power,
  Independent Director
• Argeris Karabelas,
  Independent Director
• Sarah Kavanagh,
  Independent Director
• D. Robert Hale,
  Independent Director
• Amy Wechsler,
  Independent Director
• Richard De Schutter,
  Independent Director
• Andrew Charles von Eschenbach,
  Independent Director
• John Paulson,
  Independent Director
• Tom G. Vadaketh,
  Chief Financial Officer
• Frederick J. Munsch,
  Controller & Chief Accounting Officer
• Kelly Webber,
  Sr. VP & Chief HR Officer
• Stacey Williams,
  VP of Marketing
• Michael McMyne,
  VP of Sales
• Arthur J. Shannon,
  Sr. VP and Head of Investor Relations & Communications
• Dr. Robert F. Butz,
  VP of Medical & Scientific Affairs
• Osama A. Eldessouky,
  CFO & Exec. VP
• Christian A Garcia,
  Director
• Frank D. Lee,
  Director
• Mark C. Mc Kenna,
  President, Salix
• Holdings, L.P.Value Act Hol...,
  
• Brett Icahn,
  Director
• Steven D Miller,
  Director
• Tom George Vadaketh,
  EVP, Chief Financial Officer
• Holdings, L.P.Value Act Cap...,
  
• Aimee J. Lenar,
  EVP, US Pharma
• Seana Carson,
  EVP, General Counsel
• David Robert Value Act Hold...,
  
• Sam Eldessouky,
  EVP & Chief Financial Officer
• Frederick Munsch,
  SVP, Controller and CAO
• Robert Spurr,
  President, U.S. Businesses
• Richard Mulligan,
  Director
• John S Barresi,
  SVP, Controller & CAO
• Jean Jacques Charhon,
  EVP, CFO